Skip to content
Back to all peptides

Sermorelin

GHRH 1-29GRF 1-29Growth hormone releasing hormone

A bio-identical GHRH fragment that restores natural GH pulses.

FDA-approved (Rx)Growth Hormone
RouteInjection
Molecular weight
3,357 Da
Residues
29
Half-life
~12 minutes (injection)
Typical form
Lyophilized powder, subcutaneous injection
Status
FDA-approved (Rx)
Category
Growth Hormone

Overview

Sermorelin is the biologically active 29-amino-acid fragment of growth hormone-releasing hormone (GHRH). It stimulates the pituitary to produce and release endogenous growth hormone, helping restore natural, pulsatile GH secretion. It is FDA-approved in some regions for growth hormone deficiency.

Dosing

Injection

Starting dose
200 mcg
Common dose
200–500 mcg
Frequency
1× daily (nightly)
Notes
Take before bed on an empty stomach (≥2 h after food).

Reported research/reference doses for educational purposes only. Always verify against primary literature and applicable regulations. Not medical advice.

Amino acid sequence

YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2

How it works

Sermorelin binds to GHRH receptors on pituitary somatotrophs, stimulating both the synthesis and pulsatile release of growth hormone. Because it works by boosting the body's own GH, it produces a more natural profile than direct exogenous GH replacement.

Common research uses

  • Restoring natural growth hormone pulses
  • Growth hormone deficiency diagnostics
  • Lean mass and recovery
  • Anti-aging research

Considerations

Short half-life means frequent (often nightly) dosing. Generally well tolerated but requires consistent scheduling. Prescription in some regions, research elsewhere.

Related peptides